Glioblastomas are an extremely aggressive type of brain tumor, which is why the news this week of a vaccine that has shown promise in fighting them is so exciting. And it comes right off the back of announcing another trial of the world’s first personal mRNA vaccine for melanoma, a type of skin cancer. Ian Sample talks to Prof Alan Melcher from the Institute for Cancer Research about how these vaccines work and whether they could one day be used to target cancer before it can even be detected on scans
How to listen to podcasts: everything you need to know
